Throat cancer breakthrough: less treatment may be just as effective
NCT ID NCT05119036
First seen May 23, 2026 · Last updated Jun 18, 2026 · Updated 5 times
Summary
This study looks at whether reducing or stopping additional treatments (like chemo or radiation) after surgery for HPV-positive throat cancer can still prevent the cancer from coming back. The goal is to maintain good outcomes while avoiding harsh long-term side effects. About 83 adults with HPV-positive oropharyngeal cancer are being followed to see how well this lighter approach works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IU Health Joe and Shelly Schwarz Cancer Center
Carmel, Indiana, 46032, United States
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.